Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Rheumatol Int ; 44(6): 1143-1154, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38683351

ABSTRACT

BACKGROUND: Patients with axial spondyloarthritis (axSpA) benefit from regular home-based exercise (HbE). In spite of recommendations, a relevant proportion of German axSpA patients does not adhere to recommended HbE practices. To enhance HbE care, we developed the novel digital therapeutic (DTx) "Axia" compliant with the European medical device regulation (MDR). Axia offers a modern app-based HbE solution with patient educative content and further integrated features. OBJECTIVE: We aimed to assess Axia's efficacy, attractiveness, and functionality through a survey among axSpA-patients involved in the first user tests. METHODS: A mixed-method online questionnaire with 38 items was administered to 37 axSpA volunteers after using Axia. Numeric rating scales (NRS) and likelihood scales were primarily used. RESULTS: HbE frequency significantly increased from a median of 1 day/week to 6 days/week (p < 0.001) by using Axia. Existing HbE practitioners also increased their frequency (median of 4 days/week before, 6 days/week with Axia, p < 0.05). Axia received a median rating of 5 out of 5 stars. On NRS scales, Axia scored a median of 9 for intuitiveness and design, and a median of 8 for entertainment. 64.9% reported improved range of motion, 43.2% reported reduced pain, and 93.6% enhanced disease-specific knowledge. All users recommended Axia to other patients. CONCLUSION: Axia increases axSpA patients HbE frequency, possibly due to its good intuitiveness and design, leading to reduction in pain and subjective improvement of range of motion. This warrants further investigation in large randomized controlled interventional trials to establish its efficacy conclusively and patients adherence to HbE.


Subject(s)
Axial Spondyloarthritis , Exercise Therapy , Mobile Applications , Humans , Male , Female , Cross-Sectional Studies , Adult , Middle Aged , Exercise Therapy/methods , Surveys and Questionnaires , Patient Education as Topic/methods , Germany , Patient Compliance
2.
Wien Med Wochenschr ; 2023 Oct 06.
Article in German | MEDLINE | ID: mdl-37801169

ABSTRACT

It has long been known in historical research that the Habsburg Emperor Maximilian II (1527-1576) suffered from heart complaints throughout his life. Numerous biographers mention this fact. His medical history and even the results of the autopsy of his body have been handed down; however, it has not been sufficiently investigated how Maximilian's physicians explained his heart condition, often referred to as "tremor cordis", and what causes and triggers they held responsible for this complaint in general and in the specific case of their famous patient. This article addresses these questions, primarily on the basis of a detailed consultation by the imperial personal physician Andrea Gallo, dating from 1555. Gallo's consilium, which has been ignored by scholares so far, first summarizes the state of knowledge on heart tremors at that time. It then turns to Maximilian's case and provides revealing insights into his mental state.

3.
Z Rheumatol ; 82(3): 256-261, 2023 Apr.
Article in German | MEDLINE | ID: mdl-34618212

ABSTRACT

BACKGROUND: Digital health applications/apps (DiGA) are entering many medical disciplines and have the potential to revolutionize patient care. In rheumatology, the use for axial spondyloarthritis (axSpA) would be conceivable in the form of an exercise app. Therefore, a representative survey among axSpA patients was conducted to determine the need for an axSpA exercise app. MATERIALS AND METHODS: An anonymous online survey among axSpA patients of the German Bechterew's Disease Association was conducted using a questionnaire; data were analysed using Excel, and GraphPad Prism. RESULTS: Four hundred and thirty-five axSpA patients participated in the survey. Eighty-four percent of the participants responded that there is a need to develop an axSpA-specific exercise app, and the same proportion want to use it. Patients under 60 years, patients under 60 years on biologics or Janus kinase inhibitor therapy, and patients with frequent back pain reported a greater need than their respective control subgroups (p < 0.001 in each case). CONCLUSION: The development of an exercise app for axSpA is considered necessary by a large proportion of the patients; younger and more intensively treated patients appear to have a greater need.


Subject(s)
Mobile Applications , Rheumatology , Spondylarthritis , Spondylitis, Ankylosing , Humans , Spondylarthritis/therapy , Spondylitis, Ankylosing/complications , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...